The second most mutated gene in HCC patients is TP53 and the common mutations are missense mutations, Eventually, leading to the loss of TP53 function or the gain of functions such as angiogenesis which lead to tumour formation [26]. This evidence concerns the gene TP53 and hepatocellular carcinoma.